Transforming Growth Factor β Affects Osteoclast Differentiation via Direct and Indirect Actions
J Quinn(The University of Melbourne), Matthew T. Gillespie(St Vincents Institute of Medical Research), Nobuyuki Udagawa(Matsumoto Dental University), Kanami Itoh(SHOWA Medical University), Hisataka Yasuda(SHOWA Medical University), Atsuko Mizuno(Megmilk Snow Brand (Japan)), Tatsuo Suda(SHOWA Medical University), Naoyuki Takahashi(Matsumoto Dental University), T. John Martin(St Vincent's Hospital Melbourne), K D Hausler(The University of Melbourne), Nobuyuki Shima(SHOWA Medical University), Kanji Higashio(Megmilk Snow Brand (Japan))
Cited by 278
Related Papers
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
|Proceedings of the National Academy of Sciences|1998|4.3k
Tumor Necrosis Factor α Stimulates Osteoclast Differentiation by a Mechanism Independent of the Odf/Rankl–Rank Interaction
|The Journal of Experimental Medicine|2000|1.3k
OSTEOBLASTIC CELLS ARE INVOLVED IN OSTEOCLAST FORMATION
|Endocrinology|1988|945
Regulation of Osteoblast Differentiation Mediated by Bone Morphogenetic Proteins, Hedgehogs, and Cbfa1
|Endocrine Reviews|2000|665
Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation
|Journal of Bone and Mineral Research|1996|548